Publication Information

{'id': 'https://openalex.org/W2913585936', 'doi': 'https://doi.org/10.1158/1538-7445.prca2017-a029', 'title': 'Abstract A029: Targeting neural transcription factor BRN2 in neuroendocrine prostate tumors', 'display_name': 'Abstract A029: Targeting neural transcription factor BRN2 in neuroendocrine prostate tumors', 'publication_year': 2018, 'publication_date': '2018-08-14', 'ids': {'openalex': 'https://openalex.org/W2913585936', 'doi': 'https://doi.org/10.1158/1538-7445.prca2017-a029', 'mag': '2913585936'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.prca2017-a029', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5055762119', 'display_name': 'Ravi S. N. Munuganti', 'orcid': 'https://orcid.org/0009-0006-5084-510X'}, 'institutions': [{'id': 'https://openalex.org/I141945490', 'display_name': 'University of British Columbia', 'ror': 'https://ror.org/03rmrcq20', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I141945490']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Ravi Shashi Nayana Munuganti', 'raw_affiliation_strings': ['University of British Columbia, Vancouver, BC, Canada.'], 'affiliations': [{'raw_affiliation_string': 'University of British Columbia, Vancouver, BC, Canada.', 'institution_ids': ['https://openalex.org/I141945490']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056176506', 'display_name': 'Daksh Thaper', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I141945490', 'display_name': 'University of British Columbia', 'ror': 'https://ror.org/03rmrcq20', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I141945490']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Daksh Thaper', 'raw_affiliation_strings': ['University of British Columbia, Vancouver, BC, Canada.'], 'affiliations': [{'raw_affiliation_string': 'University of British Columbia, Vancouver, BC, Canada.', 'institution_ids': ['https://openalex.org/I141945490']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5081653545', 'display_name': 'Amina Zoubeidi', 'orcid': 'https://orcid.org/0000-0002-0498-142X'}, 'institutions': [{'id': 'https://openalex.org/I141945490', 'display_name': 'University of British Columbia', 'ror': 'https://ror.org/03rmrcq20', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I141945490']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Amina Zoubeidi', 'raw_affiliation_strings': ['University of British Columbia, Vancouver, BC, Canada.'], 'affiliations': [{'raw_affiliation_string': 'University of British Columbia, Vancouver, BC, Canada.', 'institution_ids': ['https://openalex.org/I141945490']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 62}, 'biblio': {'volume': '78', 'issue': '16_Supplement', 'first_page': 'A029', 'last_page': 'A029'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9969, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9969, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9455, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10631', 'display_name': 'Cancer, Hypoxia, and Metabolism', 'score': 0.9376, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.6925855}, {'id': 'https://openalex.org/keywords/neuroendocrine-differentiation', 'display_name': 'Neuroendocrine differentiation', 'score': 0.58370054}], 'concepts': [{'id': 'https://openalex.org/C2777933648', 'wikidata': 'https://www.wikidata.org/wiki/Q21114866', 'display_name': 'SOX2', 'level': 4, 'score': 0.7251368}, {'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.6925855}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6714215}, {'id': 'https://openalex.org/C2780341458', 'wikidata': 'https://www.wikidata.org/wiki/Q18391873', 'display_name': 'Neuroendocrine differentiation', 'level': 4, 'score': 0.58370054}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.5660138}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.5108599}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.50604147}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.48860174}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.45741576}, {'id': 'https://openalex.org/C2779066768', 'wikidata': 'https://www.wikidata.org/wiki/Q1981276', 'display_name': 'Neuroendocrine tumors', 'level': 2, 'score': 0.4369573}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.3924944}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.37666434}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.22968689}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.21094275}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.09817311}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.061852127}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.prca2017-a029', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3169367773', 'https://openalex.org/W3094105955', 'https://openalex.org/W3005243004', 'https://openalex.org/W2811710613', 'https://openalex.org/W2372172309', 'https://openalex.org/W2352173395', 'https://openalex.org/W2074215098', 'https://openalex.org/W2060351647', 'https://openalex.org/W2018446432', 'https://openalex.org/W1972249865'], 'abstract_inverted_index': {'Abstract': [0], 'Introduction:': [1], 'Resistance': [2], 'to': [3, 65, 86, 133, 170, 308], 'newly': [4], 'developed': [5], 'androgen': [6], 'receptor': [7], 'pathway': [8], 'inhibitors': [9, 156, 165, 285], '(ARPIs),': [10], 'such': [11, 302], 'as': [12, 107], 'enzalutamide': [13], '(ENZ),': [14], 'rapidly': [15], 'emerges': [16], 'and': [17, 46, 64, 115, 122, 150, 193, 213, 222, 241, 293, 311, 357], 'patients': [18, 29, 316], 'generally': [19], 'die': [20], 'within': [21], 'two': [22], 'years.': [23], 'In': [24], 'particular,': [25], 'a': [26, 74, 108, 130, 173, 255, 288], 'subset': [27], 'of': [28, 80, 95, 113, 145, 161, 184, 227, 235, 245, 265, 268, 291, 301, 313, 321, 346], 'who': [30], 'relapse': [31], 'following': [32], 'ARPI': [33], 'therapy': [34], 'exhibit': [35], 'lineage': [36], 'switching': [37], 'whereby': [38], 'tumors': [39, 342], 'shed': [40], 'their': [41], 'dependence': [42], 'on': [43, 218], 'AR': [44], 'signaling': [45], 'emerge': [47], 'with': [48, 199, 230], 'neuroendocrine': [49, 55, 135, 186, 340], 'features.': [50], 'These': [51, 248], 'tumors,': [52], 'termed': [53], 'treatment-induced': [54], 'prostate': [56, 322, 341], 'cancer': [57], '(t-NEPC),': [58], 'carry': [59], 'an': [60], 'extremely': [61], 'poor': [62], 'prognosis': [63], 'date': [66], 'treatment': [67, 226, 306], 'remains': [68], 'decades-old': [69], 'cytotoxic': [70], 'chemotherapy,': [71], 'which': [72], 'carries': [73], 'short-lived': [75], 'response': [76], 'at': [77], 'the': [78, 84, 102, 142, 162, 182, 185, 233, 243, 252, 263, 279, 295, 299, 305, 347], 'cost': [79], 'significant': [81], 'toxicity.': [82], 'Thus,': [83], 'need': [85], 'develop': [87], 'targeted': [88], 'treatments': [89], 'for': [90, 157, 274, 286, 298, 315], 'this': [91], 'devastating': [92], 'disease': [93], 'is': [94, 129, 254], 'paramount': [96], 'importance.': [97], 'Recently': [98], 'our': [99], 'group': [100], 'identified': [101, 154], 'neural': [103, 335], 'transcription': [104, 336], 'factor': [105, 337], 'BRN2': [106, 128, 171, 219, 253, 338], 'major': [109], 'clinically': [110], 'relevant': [111], 'driver': [112, 290], 'NEPC': [114, 246], 'aggressive': [116], 'tumor': [117], 'growth,': [118], 'both': [119], 'in': [120, 123, 195, 202, 211, 339, 354], 'vitro': [121], 'vivo,': [124], 'suggesting': [125], 'that': [126, 251, 259], 'targeting': [127], 'promising': [131], 'strategy': [132], 'prevent': [134], 'differentiation': [136], 'or': [137], 'treat': [138], 'NEPC.': [139, 269, 277], 'Methods:': [140], 'Using': [141], 'integrated': [143], 'power': [144], 'computational': [146], 'drug': [147, 257], 'discovery': [148], 'platform': [149], 'biologic': [151], 'testing': [152], 'we': [153], 'first-in-field': [155, 284], 'BRN2.': [158], 'Results:': [159], 'One': [160], 'most': [163], 'potent': [164], 'identified,': [166], 'Cpd': [167, 228], '18,': [168], 'binds': [169], 'using': [172], 'Drug': [174], 'Affinity': [175], 'Responsive': [176], 'Target': [177], 'Stability': [178], '(DARTS)': [179], 'assay,': [180], 'decreases': [181], 'expression': [183, 244], 'genes': [187], 'SOX2,': [188], 'NCAM1,': [189], 'CGA,': [190], 'NSE,': [191], 'PEG10,': [192], 'N-Myc': [194], 'BRN2Hi': [196], 'NCI-H660': [197, 212], 'cells': [198, 237], 'similar': [200], 'effect': [201, 217], '42DENZR': [203, 214], 'cells.': [204, 224], 'Moreover,': [205], 'Cpd18': [206], 'displays': [207], 'pronounced': [208], 'antiproliferative': [209], 'activity': [210], 'without': [215], 'any': [216], 'low/neg': [220], '16DCRPC': [221, 236], 'LNCaP': [223], 'Combination': [225], '18': [229], 'ENZ': [231], 'prevents': [232], 'trans-differentiation': [234], 'into': [238, 304], 'NEPC-like': [239], 'morphology': [240], 'downregulates': [242], 'markers.': [247], 'outcomes': [249], 'confirmed': [250], 'novel': [256], 'target': [258], 'can': [260], 'help': [261], 'address': [262], 'problem': [264], 'ENZ-resistant': [266], 'form': [267, 320], 'Conclusion:': [270], 'No': [271], 'therapies': [272], 'exist': [273], 'highly': [275], 'lethal': [276], 'Hence,': [278], 'described': [280], 'work': [281], 'will': [282], 'identify': [283], 'BRN2,': [287], 'central': [289], 'NEPC,': [292], 'lay': [294], 'preclinical': [296], 'foundation': [297], 'integration': [300], 'drugs': [303], 'landscape': [307], 'improve': [309], 'survival': [310], 'quality': [312], 'life': [314], 'suffering': [317], 'from': [318], 'deadly': [319], 'cancer.': [323], 'Citation': [324], 'Format:': [325], 'Ravi': [326], 'Shashi': [327], 'Nayana': [328], 'Munuganti,': [329], 'Daksh': [330], 'Thaper,': [331], 'Amina': [332], 'Zoubeidi.': [333], 'Targeting': [334], '[abstract].': [343], 'In:': [344], 'Proceedings': [345], 'AACR': [348], 'Special': [349], 'Conference:': [350], 'Prostate': [351], 'Cancer:': [352], 'Advances': [353], 'Basic,': [355], 'Translational,': [356], 'Clinical': [358], 'Research;': [359], '2017': [360], 'Dec': [361], '2-5;': [362], 'Orlando,': [363], 'Florida.': [364], 'Philadelphia': [365], '(PA):': [366], 'AACR;': [367], 'Cancer': [368], 'Res': [369], '2018;78(16': [370], 'Suppl):Abstract': [371], 'nr': [372], 'A029.': [373]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2913585936', 'counts_by_year': [], 'updated_date': '2024-12-12T01:23:21.171226', 'created_date': '2019-02-21'}